Safety problems on Sulpiride and other 4 ingredients surfaced.

Published: 2005-04-28 07:00:00

Updated: 2005-04-28 07:00:00

The KFDA's drug safety review on 5 drugs including Sulpiride, a gastric motility enhancing drug known as 60 billion won of the market being already established, non-steroid anti-inflammatory drugs and atopic dermatological drug will be soon reported.

The safety review results will be soon reported mainly for 5 ingredients such as the NSAID drugs especially COX-2 blocker (Celebrex, Vioxx, Na...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.